← Back to Search

Continuous Glucose Monitoring

Eversense CGM for Diabetes (PAS Trial)

N/A
Waitlist Available
Research Sponsored by Senseonics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject is greater than 18 years of age
Subject has diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

PAS Trial Summary

This trial will test the long-term safety and effectiveness of the Eversense CGM system.

Who is the study for?
This trial is for adults over 18 years old with any type of diabetes. It's not suitable for those who are critically ill, hospitalized, pregnant or nursing women, or people using other CGM systems or certain insulin pumps.Check my eligibility
What is being tested?
The study tests the long-term safety and effectiveness of the Eversense® Continuous Glucose Monitoring System through multiple cycles of insertion and removal in managing diabetes.See study design
What are the potential side effects?
Possible side effects may include reactions at the sensor insertion site, inaccurate glucose readings leading to hyper- or hypoglycemia, and potential adverse reactions to dexamethasone used in the device.

PAS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.
Select...
I have diabetes.

PAS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of procedure-related adverse events
Time in Range

PAS Trial Design

1Treatment groups
Experimental Treatment
Group I: Continuous Glucose Monitoring DeviceExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Senseonics, Inc.Lead Sponsor
9 Previous Clinical Trials
1,731 Total Patients Enrolled
1 Trials studying Diabetes
925 Patients Enrolled for Diabetes

Media Library

Eversense® CGM system (Continuous Glucose Monitoring) Clinical Trial Eligibility Overview. Trial Name: NCT03908125 — N/A
Diabetes Research Study Groups: Continuous Glucose Monitoring Device
Diabetes Clinical Trial 2023: Eversense® CGM system Highlights & Side Effects. Trial Name: NCT03908125 — N/A
Eversense® CGM system (Continuous Glucose Monitoring) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03908125 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the geographical sites of implementation for this clinical trial?

"There are 14 trial sites enrolling participants in this clinical study, among which are Chesterfield, Cypress and Newport Beach. To reduce travel demands, it is preferable to choose the closest center available for enrollment."

Answered by AI

Is enrollment for this experiment still open to members of the public?

"Per the clinicaltrials.gov records, this clinical trial is not presently recruiting patients; it was initially posted on March 19th 2019 and last updated on November 10th 2022. However, there are a plethora of other trials looking for participants with 1477 studies in search of volunteers at the moment."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
65+
What site did they apply to?
The Center for Diabetes and Endocrine Care
Hoag Memorial Hospital Presbyterian/Mary Dick Allen Diabetes Center
Diabetes & Endocrinology Consultants of Pennsylvania, LLC
Other
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
1

Why did patients apply to this trial?

I continually have an A1c higher than desired. Maybe this trial will help.
PatientReceived no prior treatments
I’m hoping this clinical trial helps me to take care with more accuracy of my health condition.
PatientReceived no prior treatments
Want to control my A1c and lowering my sugars would love to get into this program Nadia Khoury is another physician can call (734) 282-3137 that would have my medical information.
PatientReceived 1 prior treatment
During my 24 year journey with Diabetes I have always looked for new and different tools to control the disease. I am insulin resistant so there are NO easy medical answer's to controlling sugars. Which inspires me to be willing to try new and different tools.
PatientReceived no prior treatments
I've been a type one diabetic since I was 12 and it has been a constant struggle. I have problems keeping it normal all the time. I have such a weird relationship with food now because of it. I'm willing to try a lot but I can only travel so far. But if there's a chance one of these trials can help me maintain or even cure my condition then I will figure it out. I really need this.
PatientReceived 1 prior treatment

How responsive is this trial?

Average response time
  • < 1 Day
Typically responds via
Email
Most responsive sites:
  1. Diabetes and Glandular Disease Clinic: < 24 hours
Recent research and studies
clinicaltrials.govStudy
Post Approval Study of the Eversense® Continuous Glucose Monitoring
2019. "Post Approval Study of the Eversense® Continuous Glucose Monitoring". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03908125.
All > Type 1 Diabetes > Diabetes Type 2
~45 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top